HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Roles of intrinsic angiogenesis inhibitor, vasohibin, in cervical carcinomas.

Abstract
The aim of the present study is to clarify the critical roles of vasohibin in cervical carcinomas. We investigated the expression ratios of vasohibin and vascular endothelial growth factor (VEGF) receptor-2 on endothelium and microvessel density, lymphatic vessel density (LVD) by immunohistochemistry. Sixty-one squamous cell carcinoma (SCC), 18 mucinous adenocarcinoma (Adenocarcinoma), 38 carcinoma in situ (CIS), and 35 normal cervical epithelium were collected. We investigated the expression of vasohibin and compared it with the expression of VEGF receptor-2 (VEGFR-2, KDR/flk-1), and CD34 in the stromal endothelium. Expression of VEGF was counted using the histological score (H score). D2-40 was used as a marker for lymphatic endothelial cells to investigate LVD. The microvessel density of the normal cervical epithelium was significantly lower than that of CIS, SCC, and Adenocarcinoma (P < 0.05). The expression ratio of vasohibin in the normal cervical epithelium was significantly lower than that of SCC and Adenocarcinoma (P < 0.05). The expression ratio of VEGFR-2 of the normal cervical epithelium was significantly lower than that of SCC and Adenocarcinoma (P < 0.05). The LVD of the normal cervical epithelium was significantly lower than that of CIS, SCC, and Adenocarcinoma (P < 0.05). For normal cervical epithelium, CIS, and SCC, there was a moderate correlation between the expression percentage of vasohibin and the expression percentage of VEGFR-2 (P < 0.05, r(2) = 0.3018). This is the first study to elucidate the correlation between the expression of vasohibin in the stromal endothelial cells and the expression of VEGFR-2 in human cervical carcinomas.
AuthorsKousuke Yoshinaga, Kiyoshi Ito, Takuya Moriya, Satoru Nagase, Tadao Takano, Hitoshi Niikura, Hironobu Sasano, Nobuo Yaegashi, Yasufumi Sato
JournalCancer science (Cancer Sci) Vol. 102 Issue 2 Pg. 446-51 (Feb 2011) ISSN: 1349-7006 [Electronic] England
PMID21175993 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2010 Japanese Cancer Association.
Chemical References
  • Cell Cycle Proteins
  • VASH1 protein, human
  • Vascular Endothelial Growth Factor Receptor-2
Topics
  • Adult
  • Carcinoma (blood supply, metabolism, pathology)
  • Cell Cycle Proteins (biosynthesis)
  • Female
  • Gene Expression
  • Humans
  • Immunohistochemistry
  • Lymphatic Vessels (metabolism, pathology)
  • Middle Aged
  • Neovascularization, Pathologic (metabolism, pathology)
  • Uterine Cervical Neoplasms (blood supply, metabolism, pathology)
  • Vascular Endothelial Growth Factor Receptor-2 (biosynthesis)
  • Uterine Cervical Dysplasia (blood supply, metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: